Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026

Rhea-AI Summary

Lucid Diagnostics (Nasdaq: LUCD) will host a business update conference call and webcast on Thursday, May 14, 2026 at 8:30 AM ET. CEO Lishan Aklog will provide a business update and CFO Dennis McGrath will discuss first quarter 2026 financial results.

The live webcast and a 30-day replay will be available on the company's investor relations website at luciddx.com. Telephone access is available for U.S. and international listeners with provided dial-in numbers; attendees should reference the conference call name "Lucid Diagnostics Business Update."

AI-generated analysis. Not financial advice.

News Market Reaction – LUCD

+3.88%

1 alert

+3.88% News Effect

On the day this news was published, LUCD gained 3.88%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Conference Call and Webcast at 8:30 AM ET

NEW YORK, April 30, 2026 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that it will host a business update conference call and webcast on Thursday, May 14, 2026, at 8:30 AM ET. During the call, Lishan Aklog, M.D., Lucid's Chairman and Chief Executive Officer, will provide a business update and discuss the Company's operations and growth strategy. In addition, Dennis McGrath, Lucid's Chief Financial Officer, will discuss the Company's first quarter 2026 financial results.

The webcast will be available at the investor relations section of the Company's website at luciddx.com. Alternatively, to access the conference call by telephone, U.S.-based callers should dial 1-800-836-8184 and international listeners should dial 1-646-357-8785. All listeners should provide the operator with the conference call name "Lucid Diagnostics Business Update" to join.

Following the conclusion of the conference call, a replay will be available for 30 days on the investor relations section of the Company's website at luciddx.com.

About Lucid Diagnostics
Lucid Diagnostics Inc. is a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM). Lucid is focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, who are at risk of developing esophageal precancer and cancer. Lucid's EsoGuard^® Esophageal DNA Test, performed on samples collected in a brief, noninvasive office procedure with its EsoCheck^® Esophageal Cell Collection Device, represent the first and only commercially available tools designed with the goal of preventing cancer and cancer deaths through widespread, early detection of esophageal precancer in at-risk patients.

For more information, please visit www.luciddx.com and for more information about its parent company PAVmed, please visit www.pavmed.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/lucid-diagnostics-to-hold-first-quarter-2026-business-update-conference-call-and-webcast-on-may-14-2026-302758598.html

SOURCE Lucid Diagnostics

FAQ

When is the Lucid Diagnostics (LUCD) business update conference call?

Lucid Diagnostics (LUCD) will hold its business update conference call on Thursday, May 14, 2026 at 8:30 AM ET. According to the company, the event will include a live webcast and a telephone dial-in for U.S. and international listeners.

How can I access the Lucid Diagnostics (LUCD) webcast for the May 14, 2026 call?

Access the Lucid Diagnostics (LUCD) webcast via the investor relations website at luciddx.com during the live event. According to the company, a replay of the webcast will be available on the same site for 30 days after the call.

What topics will Lucid Diagnostics (LUCD) cover on the May 14, 2026 call?

The company will provide a business update and discuss first quarter 2026 financial results on the May 14, 2026 call. According to the company, the CEO will outline operations and growth strategy while the CFO presents financial results.

Who are the presenters on Lucid Diagnostics (LUCD) May 14, 2026 business update call?

Lucid Diagnostics (LUCD) said CEO Lishan Aklog and CFO Dennis McGrath will lead the May 14, 2026 call. According to the company, Aklog will discuss business strategy and McGrath will review first quarter 2026 financial results.

What phone numbers can I use to join the Lucid Diagnostics (LUCD) May 14, 2026 call?

U.S. callers can dial 1-800-836-8184 and international listeners can dial 1-646-357-8785 to join the call. According to the company, callers should provide the conference call name "Lucid Diagnostics Business Update" to the operator.